[go: up one dir, main page]

NO943388D0 - Selective change of antibody immunogenicity - Google Patents

Selective change of antibody immunogenicity

Info

Publication number
NO943388D0
NO943388D0 NO943388A NO943388A NO943388D0 NO 943388 D0 NO943388 D0 NO 943388D0 NO 943388 A NO943388 A NO 943388A NO 943388 A NO943388 A NO 943388A NO 943388 D0 NO943388 D0 NO 943388D0
Authority
NO
Norway
Prior art keywords
selective change
antibody immunogenicity
immunogenicity
antibody
selective
Prior art date
Application number
NO943388A
Other languages
Norwegian (no)
Other versions
NO943388L (en
Inventor
Thomas R Sykes
Mark Reddish
Richard P Baum
Antoine A Noujaim
Original Assignee
Biomira Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomira Inc filed Critical Biomira Inc
Publication of NO943388D0 publication Critical patent/NO943388D0/en
Publication of NO943388L publication Critical patent/NO943388L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1078—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody the antibody being against an immunoglobulin, i.e. being an (anti)-anti-idiotypic antibody
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • C07K16/4266—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig against anti-tumor receptor Ig
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO943388A 1992-03-18 1994-09-12 Selective change of antibody immunogenicity NO943388L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85360592A 1992-03-18 1992-03-18
PCT/CA1993/000110 WO1993018792A1 (en) 1992-03-18 1993-03-18 Selective alteration of antibody immunogenicity

Publications (2)

Publication Number Publication Date
NO943388D0 true NO943388D0 (en) 1994-09-12
NO943388L NO943388L (en) 1994-11-18

Family

ID=25316485

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943388A NO943388L (en) 1992-03-18 1994-09-12 Selective change of antibody immunogenicity

Country Status (7)

Country Link
EP (1) EP0631507A1 (en)
JP (1) JPH07504668A (en)
AU (1) AU3881593A (en)
CA (1) CA2131621A1 (en)
FI (1) FI944314A0 (en)
NO (1) NO943388L (en)
WO (1) WO1993018792A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL121041A0 (en) * 1997-06-09 1997-11-20 Yeda Res & Dev Immunogenic compositions for induction of anti-tumor immunity
JP2002504154A (en) * 1997-06-17 2002-02-05 アルタレックス コーポレイション Therapeutic compositions and methods of treatment
CA2777527C (en) 2009-12-23 2020-06-23 Esbatech, An Alcon Biomedical Research Unit Llc Method for decreasing immunogenicity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4661586A (en) * 1981-11-17 1987-04-28 The Board Of Trustees Of The Leland Stanford Junior University Monoclonal anti-idiotype antibodies
US4816249A (en) * 1981-11-17 1989-03-28 The Board Of Trustees Of The Leland Stanford Junior University Monoclonal anti-idiotype antibodies

Also Published As

Publication number Publication date
CA2131621A1 (en) 1993-09-30
EP0631507A1 (en) 1995-01-04
FI944314L (en) 1994-09-16
FI944314A7 (en) 1994-09-16
FI944314A0 (en) 1994-09-16
AU3881593A (en) 1993-10-21
WO1993018792A1 (en) 1993-09-30
JPH07504668A (en) 1995-05-25
NO943388L (en) 1994-11-18

Similar Documents

Publication Publication Date Title
DE69232604D1 (en) ANTIBODY CONSTRUCTS
FI934261L (en) Foerfarande Foer framstaellning av en bilvindruta foersedd med elastram av bestaemd form
FI932515L (en) FOERFARANDE FOER FRAMSTAELLNING AV AETTIKSYRA
FI933104A0 (en) FOERFARANDE FOER DELIGNIFIERING AV KEMISK PAPPERSMASSA
FI924590L (en) Foerfarande Foer framstaellning av laekemedelskorn
FI931372A7 (en) FOERFARANDE FOER BEHANDLING AV RUMSLUFT FOER MAENSKOR
FI934151A7 (en) Foerfarande Foer framstaellning av en baerarkatalyst Foer polymerisationav a-olefiner
FI930281L (en) REACTIVERING AV HYDROFORMYLERINGSKATALYSATORER
FI933902L (en) Substituerade cyklohexanderivat Foer behandling av dykek
FI935054A0 (en) Bestaemning av saendningskanal
FI934625L (en) Sulfonamidderivat av benzenfusionerade hydroxisubstituerade cykloalkyl- och heterocykliska ringfoereningar
FI932848L (en) FOERFARANDE FOER BLEKNING AV PAPPERSMASSA
FI932726L (en) FOERFARANDE FOER FRAMSTAELLNING AV NICKELHYDROXID
FI931013L (en) FORM FOER FRAMSTAELLNING AV LATEXSKUMPLAST
FI931677L (en) FOERFARANDE FOER PAOVISNING AV NUKLEINSYROR
FI934299A0 (en) FOERFARANDE FOER KATALYTISK AKTIVERING AV EN KATOD
NO943388D0 (en) Selective change of antibody immunogenicity
FI932375L (en) ANVAENDNING AV AMORFISK SILICOALUMINAT FOER AVLAEGSNING AV KALCIUMUTFAELLNINGAR
FI931086L (en) FOERFARANDE FOER FRAMSTAELLNING AV KOLHYDRATER
FI935429A0 (en) Foerfarande Foer framstaellning av proteinprodukter Foer ljusa pappersbelaeggningar
FI930339L (en) FOERFARANDE FOER TEMPORAER ALLOKERING AV DUBBELRIKTAD SAENDNING
FI932697L (en) FOERFARANDE FOER FRAMSTAELLNING AV TETRONSYRAALKYLESTRAR
FI933152L (en) FOERFARANDE FOER FRAMSTAELLNING AV OXAMID-KORN
FI934283A7 (en) Foerfarande Foer foeraedling av avvalstryckpapper
FI931127A7 (en) Anordning Foer behandling av kortformiga databaerare